Zdrowie i gospodarka · 12.12.1997
Iron-Containing Supplements and Drugs: Label Warning Statements and Unit-Dose Packaging Requirements; Small Entity Compliance Guide; Availability
The Food and Drug Administration (FDA) is announcing the availability of a small entity compliance guide entitled ``Iron- Containing Supplements and Drugs: Label Warning Statements and Unit- Dose Packaging Requirements; Small Entity Compliance Guide'' (compliance guide). This compliance guide is intended to help small entities comply with the final rule requiring label warnings and unit- dose packaging for iron-containing supplements and drug products. This action is being taken under the Small Business Regulatory Enforcement Fairness Act of 1996 (the SBREFA).